• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California.

作者信息

Gubatan John, Levitte Steven, Balabanis Tatiana, Patel Akshar, Sharma Arpita, Habtezion Aida

机构信息

Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.

Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California; Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

出版信息

Gastroenterology. 2020 Sep;159(3):1141-1144.e2. doi: 10.1053/j.gastro.2020.05.009. Epub 2020 May 7.

DOI:10.1053/j.gastro.2020.05.009
PMID:32387541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7204754/
Abstract
摘要

相似文献

1
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California.加利福尼亚北部炎症性肠病患者中2019冠状病毒病的严重急性呼吸综合征冠状病毒2检测、患病率及预测因素
Gastroenterology. 2020 Sep;159(3):1141-1144.e2. doi: 10.1053/j.gastro.2020.05.009. Epub 2020 May 7.
2
Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.意大利北部严重急性呼吸综合征冠状病毒2疫情期间炎症性肠病患者的平稳病程
Gastroenterology. 2020 Jul;159(1):371-372. doi: 10.1053/j.gastro.2020.03.062. Epub 2020 Apr 2.
3
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.炎症性肠病患者的新型冠状病毒肺炎：意大利北部的一项单中心观察性研究。
Inflamm Bowel Dis. 2020 Oct 23;26(11):e138-e139. doi: 10.1093/ibd/izaa244.
4
Are we underestimating seroprevalence of SARS-CoV-2?我们是否低估了新冠病毒的血清阳性率？
BMJ. 2020 Sep 3;370:m3364. doi: 10.1136/bmj.m3364.
5
2019 Novel Coronavirus-Important Information for Clinicians.2019新型冠状病毒——临床医生重要信息
JAMA. 2020 Mar 17;323(11):1039-1040. doi: 10.1001/jama.2020.1490.
6
Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.严重急性呼吸综合征冠状病毒2诊断检测特刊及本次大流行的经验教训
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01324-20.
7
[COVID-19 and Pulmonology: New Challenges and Opportunities].[新型冠状病毒肺炎与肺病学：新挑战与新机遇]
Acta Med Port. 2020 Oct 1;33(10):710. doi: 10.20344/amp.14760. Epub 2020 Sep 2.
8
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease.炎症性肠病患者 COVID-19 的流行病学及治疗对结局的影响。
Am J Gastroenterol. 2020 Oct;115(10):1722-1724. doi: 10.14309/ajg.0000000000000830.
9
Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.冠状病毒与炎症性肠病患者：临床医生的管理策略
Am J Gastroenterol. 2020 Oct;115(10):1566-1569. doi: 10.14309/ajg.0000000000000817.
10
Late Diagnosis of COVID-19 in Patients Admitted to the Hospital.入院患者中新冠肺炎的延迟诊断
J Gen Intern Med. 2020 Sep;35(9):2829-2831. doi: 10.1007/s11606-020-05949-1. Epub 2020 Jun 15.

引用本文的文献

1
SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis.炎症性肠病患者新冠疫苗接种后出现的新冠病毒突破性感染：一项系统评价与荟萃分析
Therap Adv Gastroenterol. 2023 Jul 15;16:17562848231174295. doi: 10.1177/17562848231174295. eCollection 2023.
2
Inflammatory Bowel Disease during COVID-19 Pandemic: A Prospective Cohort Study of Incidence Rate and Patients' Concerns.新冠疫情期间的炎症性肠病：发病率及患者担忧的前瞻性队列研究
Middle East J Dig Dis. 2022 Jan;14(1):24-33. doi: 10.34172/mejdd.2022.252. Epub 2022 Jan 30.
3
Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis.炎症性肠病与 COVID-19 结局：荟萃分析。
Sci Rep. 2022 Dec 9;12(1):21333. doi: 10.1038/s41598-022-25429-2.
4
Impact of COVID-19 on Patients with Inflammatory Bowel Disease.2019年冠状病毒病对炎症性肠病患者的影响。
J Explor Res Pharmacol. 2022 Mar;7(1):37-44. doi: 10.14218/jerp.2021.00014. Epub 2021 Oct 12.
5
Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.炎症性肠病患者感染 SARS-CoV-2 及对 COVID-19 疫苗免疫应答的风险：当前证据。
Front Immunol. 2022 Jun 23;13:933774. doi: 10.3389/fimmu.2022.933774. eCollection 2022.
6
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.临床实践新进展：COVID-19 大流行期间炎症性肠病的管理。
Gut. 2022 Jul;71(7):1426-1439. doi: 10.1136/gutjnl-2021-326784. Epub 2022 Apr 27.
7
Impact of biologics and small molecules for inflammatory bowel disease on COVID-19-related hospitalization and mortality: A systematic review and meta-analysis.生物制剂和小分子药物对炎症性肠病患者COVID-19相关住院率和死亡率的影响：一项系统评价和荟萃分析
JGH Open. 2022 Mar 20;6(4):241-250. doi: 10.1002/jgh3.12728. eCollection 2022 Apr.
8
Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements.韩国肠道疾病研究协会关于2019冠状病毒病大流行期间成人炎症性肠病临床实践的指南：专家共识声明
Intest Res. 2022 Oct;20(4):431-444. doi: 10.5217/ir.2021.00111. Epub 2022 Jan 5.
9
Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study.韩国炎症性肠病患者 COVID-19 的临床病程：KASID 多中心研究。
J Korean Med Sci. 2021 Dec 13;36(48):e336. doi: 10.3346/jkms.2021.36.e336.
10
Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment.JAK抑制剂在炎症性肠病治疗中的疗效、安全性及未来展望
J Clin Med. 2021 Nov 30;10(23):5660. doi: 10.3390/jcm10235660.

本文引用的文献

1
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤：管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
2
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.冠状病毒病（COVID-19）疫情的流行病学和发病机制。
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
3
Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study.炎症性肠病中替代性肾素-血管紧张素系统循环成分的上调：一项初步研究。
J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):559-69. doi: 10.1177/1470320314521086. Epub 2014 Feb 6.